scispace - formally typeset
Y

Yukihiro Yokoyama

Researcher at Nagoya University

Publications -  342
Citations -  10921

Yukihiro Yokoyama is an academic researcher from Nagoya University. The author has contributed to research in topics: Hepatectomy & Bile duct. The author has an hindex of 43, co-authored 319 publications receiving 8835 citations. Previous affiliations of Yukihiro Yokoyama include University of North Carolina at Chapel Hill & University of North Carolina at Charlotte.

Papers
More filters
Journal ArticleDOI

Clinical importance of "occult-bacterial translocation" in patients undergoing highly invasive gastrointestinal surgery: A review.

TL;DR: Using the RT-qPCR system, it is possible to detect the specific bacteria that cause O-BT immediately after surgery, which may allow us to select the exact antibiotic that targets possible pathogenic bacteria of POICs.
Journal ArticleDOI

Does inchinkoto, a herbal medicine, have hepatoprotective effects in major hepatectomy? A prospective randomized study

TL;DR: The preoperative administration of inchinkoto did not have a significant impact on the overall outcome of major hepatectomy, but there was a significantly higher induction of antioxidant factors in the liver, such as Nrf2 protein and heme oxygenase-1 mRNA, after hepATEctomy in the inchinkotos group than in the non-inchinkoto group.
Journal ArticleDOI

Infraportal bile duct of the caudate lobe: a troublesome anatomic variation in right-sided hepatectomy for perihilar cholangiocarcinoma.

TL;DR: Infraportal B1 can cause difficulties in performing right-sided hepatectomy with caudate lobectomy or harvesting the left side of the liver with the left caudates lobe for transplantation, so Hepatobiliary and transplant surgeons should carefully evaluate biliary anatomy at the hepatic hilum, keeping this variation in mind.
Journal ArticleDOI

Liver regeneration following experimental major hepatectomy with choledochojejunostomy

TL;DR: Surgical treatment for perihilar cholangiocarcinoma frequently involves hepatectomy and extrahepatic bile duct resection with a choledochojejunostomy (CJ).
Journal ArticleDOI

The Anticancer Effects of Novel α-Bisabolol Derivatives Against Pancreatic Cancer.

TL;DR: Data indicate that α-bisabolol derivative 5 effectively prevents the progression of pancreatic cancer via inhibition of AKT, and shows that this compound has attractive therapeutic properties as a novel anticancer drug for pancreaticcancer.